Navigation Links
Inspire Announces Positive Results of Phase 2 Trial of Epinastine,Nasal Spray for Seasonal Allergic Rhinitis

liefs are based on preliminary information and management assumptions. Specifically, no assurances can be made with respect to: the initiation, timing and results of a 6-month nasal toxicology study; the importance and potential differentiating quality of the product candidate's taste profile; and the timing or outcome of the Company's meetings with the FDA regarding the epinastine nasal spray clinical program. Such forward-looking statements are subject to a wide range of risks and uncertainties that could cause results to differ in material respects, including those relating to additional clinical trials or discussions with the FDA regarding the epinastine nasal spray program, the amount of net sales of Restasis recorded by Allergan in 2007, the Company's 2007 financial results, including without limitation aggregate revenue, aggregate expenses, research and development expenses, selling and marketing expenses, general and administrative expenses, as well as the impact of the anticipated AzaSite launch, including without limitation headcount changes, related stock-based compensation expense changes, a draw on the Company's existing debt facility, the timing of any revised guidance, the timing and success of any additional capital raising activities, product development, revenue, expense and earnings expectations, the seasonality of Elestat, intellectual property rights, adverse litigation developments, adverse developments in the U.S. Securities and Exchange Commission (SEC) investigation, competitive products, results and timing of clinical trials, success of marketing efforts, the need for additional research and testing, delays in manufacturing, funding, and the timing and content of decisions made by regulatory authorities, including the U.S. Food and Drug Administration. Further information regarding factors that could affect Inspire's results is included in Inspire's filings with the SEC. Inspire undertakes no obligation to publicly release the results of an
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Inspire Announces Presentations at Two European Scientific Conferences
3. Inspire Announces Presentations at 2007 Association for Research in Vision and Ophthalmology Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:7/21/2014)... 21, 2014 Companies that supply Durable ... often contact consumers directly about purchasing such supplies ... use. The American Osteopathic Association,s House of Delegates ... from companies that supply Durable Medical Equipment unless ... the physician and the patient. ...
(Date:7/21/2014)... , July 21, 2014 /PRNewswire-iReach/ -- Top Brooklyn ... Pediatrics responds to an article, which suggests that caffeine ... Logo - http://photos.prnewswire.com/prnh/20140718/128611 A ... giving coffee to children, but now it happens rather ... A new study, published in the journal Pediatrics, discussed ...
(Date:7/21/2014)... LOS ANGELES , July 21, 2014 ... Procurement Agency (LOPA) is utilizing the CompuMed, ... (OPO) Solution to improve donor organ recovery. ... platform to provide real-time access to its ... critical care consulting.      (Logo: ...
Breaking Medicine Technology:American Osteopathic Association Calls for Eliminating Unsolicited Requests to Purchase Medical Equipment 2Dr. Michael Gabriel a Brooklyn Pediatrician Comments on an Article, Which Suggests Caffeine May Be Dangerous for Children 2Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts 2Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts 3
(Date:7/22/2014)... (PRWEB) July 22, 2014 Dr. Larry ... gathered at the MGE Management Experts Benefit Dinner May ... leaders also helped to raise funds for the Improving ... Girls Clubs and Youth Programs. The funds raised are ... to tackle illiteracy and help break the cycle of ...
(Date:7/22/2014)... 2014 An Ideal Location , Narconon ... the naturally tranquil and very beautiful Arrowhead State Park, ... ideal for both a rehabilitative setting, as well as ... display of fireworks. Launched over the waters of ... swimming in the lake, or from the nearby campgrounds ...
(Date:7/22/2014)... St. Petersburg, FL (PRWEB) July 22, 2014 ... movement to cure paralysis in the next decade is Paralympic ... of a snowboarding accident, French became a quadriplegic from a ... new effort to help find a cure for paralysis. , ... again and for others, it’s something else. We have the ...
(Date:7/22/2014)... JumpSoft, Inc., a next generation ... at the application level, today released its “App-Hugger” ... management. , Based on in-depth, one-on-one ... provides insights, context and depth regarding the challenges ... system uptime. London, Ink, a B2B marketing consulting ...
(Date:7/22/2014)... 22, 2014 The demand for revision surgeries ... whose waiting rooms are filled with patients who seek out ... people electing to have plastic surgery continues to rise across ... cosmetic procedures is increasing, it is not surprising that the ... , According to New York City Facial Plastic Surgeon ...
Breaking Medicine News(10 mins):Health News:Dr. Larry Kaplan Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 2Health News:Dr. Larry Kaplan Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 3Health News:Narconon Arrowhead Holds Annual Firework Event 2Health News:Narconon Arrowhead Holds Annual Firework Event 3Health News:Paralympian Jen French Announced as Conquer Paralysis Now’s First Champion 2Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 2Health News:JumpSoft Releases Report on Shift from Infrastructure-Centric to Application-Centric IT Management 3Health News:Cosmetic Surgery Regret Is On The Rise 2Health News:Cosmetic Surgery Regret Is On The Rise 3
... 13 Quintiles,Transnational Corp. today announced that its ... College of American Pathologists (CAP)., The central ... the first,quarter of 2007. The facility has seen ... capabilities to a growing test menu., "CAP ...
... a press conference hosted by New York,Attorney General Andrew ... probe of 16 national health insurers regarding an alleged,scheme ... The following is,attributable to Nancy H. Nielsen, M.D., Ph.D., ... York Attorney General Andrew,Cuomo calls into question the validity ...
... of Alberta study, analyzing a sample of over 275,000 ... in physical activity, one size does not fit all. ... when deciding how and if a person wants to ... at the University of Alberta. It is clear that ...
... NEW YORK, Feb. 13 Today, more than ... challenges from,all sides. Internally, the pressure to fill ... generics demand new outcomes from,pharmaceutical marketing and sales ... regulatory (e.g. post-approval monitoring),legislative, and patent issues continue ...
... VALLEY, Calif., Feb. 13 Sun Busters(R), the swim,wear ... and providing,the ultimate in sun protection now sports a ... of Recommendation! Sun Busters is proud,to announce that they ... products that have a UPF of 50+. UPF is ...
... Feb. 13 Statistics released by the,Centers for Disease ... American children is affected by autism. In Georgia, these ... that is rising in,prevalence with alarming speed. It is ... Georgia are affected by autism, a disorder of,unknown origin ...
Cached Medicine News:Health News:Quintiles Central Laboratory in India Receives CAP Certification 2Health News:AMA Commends N.Y. Investigation of Health Insurers 2Health News:Study: When it comes to physical activity, one size does not fit all 2Health News:Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 3Health News:2008 Georgia Walk for Autism Supporters Gather in Atlanta for Kick-Off Dinner 2
HemataSTAT II has a manual reader. It uses both 0.5 and 1.1 ID capillary tubes., , Spins in just 60 seconds , Built-in reader with LCD display , Accuracy comparable to NCCLS reference method , Lid lo...
... the easiest test to use on the market. ... no hands-on time. Critical care instructions can be ... the pediatrician's office. Valuable information can be obtained ... Now the focus can be on the results ...
The QuickScreen Pro Multi Drug Screening Test is a rapid, self-timing, qualitative immunoassay for,the detection of drugs of abuse in urine....
... Tests are qualitative immunoassays for detecting elevated levels ... is fast and results are easy to interpret. ... darker than the control band, then ovulation will ... If the test band does not appear or ...
Medicine Products: